GENE ONLINE|News &
Opinion
Blog

Protein Degraders
Funding Protein Degraders
Proxygen Eligible For €495 Million in Molecular Glue Degrader Collaboration with Merck KGaA
2022-06-06
Deals SK Biopharmaceuticals
SK Biopharma Teams Up with Targeted Protein Degrader Ubix
2022-04-15
Funding Targeted Protein Degradation
Plexium Bags $102 Million for Targeted Protein Degraders
2022-02-24
Funding Protein Degradation Therapeutics
Monte Rosa Bags $95 Million Series C Funding to Advance Protein Degraders
2021-03-14
R&D Proteasome
SK Holdings Supports Roivant’s New Protein Degradation Platform with US$ 200 Million Investment
2020-12-13
LATEST
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top